Outset Medical INC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$2.5Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
720clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $143K
2020 $459K
2021 $347K
2022 $720K
2023 $593K
2024 $161K
2025 $56K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Nephrology (Internal Medicine) $2.2M
Family $166K
Pediatrics $23K
Internal Medicine $13K
Critical Care Medicine (Internal Medicine) $5,088
Acute Care (Nurse Practitioner) $1,736

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Luis Alvarez Palo Alto, CA Nephrology (Internal Medicine) $719,290.90
Glenn Chertow Stanford, CA Nephrology (Internal Medicine) $642,016.43
Geoffrey Block Lone Tree, CO Nephrology (Internal Medicine) $173,260.00
Victor Tatis De La Nuez Miramar, FL Family $161,192.13
Michael Aragon Fort Worth, TX Nephrology (Internal Medicine) $137,406.59
Sevag Demirjian Cleveland, OH Nephrology (Internal Medicine) $130,880.07
Luke Basdeo Port Orange, FL Nephrology (Internal Medicine) $54,440.14
Varshasb Broumand San Antonio, TX Nephrology (Internal Medicine) $42,900.36
David Henner Pittsfield, MA Nephrology (Internal Medicine) $29,630.80
Jose Arrascue Atlantis, FL Nephrology (Internal Medicine) $29,529.25

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.